Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Carriage Services
CSV
$641M
| $1.51M | ﹤0.01% |
23,419
+15,427
| +193% | +$799K |
|
2552
CALL
Fortinet
FTNT
$119B
| $1.51M | ﹤0.01% |
21,000
| – | – |
|
|
MNRL
2553
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $1.5M | ﹤0.01% |
71,001
+237
| +0.3% | +$5.17K |
|
2554
Allogene Therapeutics
ALLO
$649M
| $1.5M | ﹤0.01% |
100,332
+56,582
| +129% | +$998K |
|
2555
Azenta
AZTA
$1.3B
| $1.49M | ﹤0.01% |
14,453
-20,981
| -59% | -$2.27M |
|
2556
MBIA
MBI
$261M
| $1.49M | ﹤0.01% |
94,211
+37,770
| +67% | +$499K |
|
|
ABTX
2557
DELISTED
Allegiance Bancshares
ABTX
| $1.49M | ﹤0.01% |
35,255
+12,719
| +56% | +$519K |
|
2558
CALL
Murphy Oil
MUR
$5.7B
| $1.49M | ﹤0.01% |
+56,900
| New | +$1.57M |
|
2559
QuidelOrtho
QDEL
$1.14B
| $1.49M | ﹤0.01% |
10,999
-12,866
| -54% | -$1.79M |
|
2560
Matthews International
MATW
$866M
| $1.48M | ﹤0.01% |
40,469
-8,634
| -18% | -$313K |
|
2561
Movado Group
MOV
$849M
| $1.48M | ﹤0.01% |
35,492
+13,964
| +65% | +$528K |
|
2562
Innoviva
INVA
$1.55B
| $1.48M | ﹤0.01% |
85,813
+13,446
| +19% | +$229K |
|
2563
Adtran
ADTN
$689M
| $1.48M | ﹤0.01% |
64,637
+24,646
| +62% | +$499K |
|
|
KYNB
2564
Kyntra Bio
KYNB
$27.2M
| $1.47M | ﹤0.01% |
4,181
+2,737
| +190% | +$852K |
|
|
EVOP
2565
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $1.47M | ﹤0.01% |
57,509
+34,285
| +148% | +$785K |
|
|
WOW
2566
DELISTED
WideOpenWest
WOW
| $1.47M | ﹤0.01% |
68,382
+37,148
| +119% | +$740K |
|
2567
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.3B
| $1.47M | ﹤0.01% |
26,000
| – | – |
|
2568
Acadia Healthcare
ACHC
$2.76B
| $1.46M | ﹤0.01% |
24,057
-27,512
| -53% | -$1.64M |
|
2569
Aclaris Therapeutics
ACRS
$726M
| $1.46M | ﹤0.01% |
100,518
+50,349
| +100% | +$763K |
|
2570
Clear Channel Outdoor Holdings
CCO
$1.23B
| $1.46M | ﹤0.01% |
440,867
+292,435
| +197% | +$910K |
|
2571
Children's Place
PLCE
$54.3M
| $1.46M | ﹤0.01% |
18,395
+5,683
| +45% | +$500K |
|
|
HSII
2572
DELISTED
Heidrick & Struggles
HSII
| $1.46M | ﹤0.01% |
33,273
+4,368
| +15% | +$199K |
|
2573
Pegasystems
PEGA
$5.02B
| $1.46M | ﹤0.01% |
26,014
+20,298
| +355% | +$1.2M |
|
|
INVX
2574
Innovex International
INVX
$1.96B
| $1.45M | ﹤0.01% |
73,833
+20,580
| +39% | +$453K |
|
2575
Curis
CRIS
$9.78M
| $1.45M | ﹤0.01% |
763
+360
| +89% | +$856K |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.